Table 1.
Dextran Distribution Differences Shown as Percent of Total Injected
| Hours after Injection | Eye | Lymph Nodes* | Total | Unaccounted | |
|---|---|---|---|---|---|
| 40 kDa | 2 | 20.6 | 10.5 | 31.1 | 68.9 |
| 4 | 10.7 | 52.6 | 63.3 | 36.7 | |
| 6 | 17.1 | 3.6 | 20.7 | 79.3 | |
| 12 | 7.0 | 52.1 | 59.0 | 41.0 | |
| 24 | 10.7 | 47.0 | 57.7 | 42.3 | |
| 72 | 0 | 23.2 | 23.2 | 76.8 | |
| 3 kDa | 2 | 1.0 | 0 | 1.0 | 99.0 |
| 4 | 1.6 | 0 | 1.6 | 98.4 | |
| 6 | 2.4 | 0 | 2.4 | 97.6 | |
| 12 | 0 | 0 | 0 | 100 | |
| 24 | 0 | 0 | 0 | 100 | |
| 72 | 0 | 0 | 0 | 100 | |
| 500 kDa | 2 | 7.4 | 1.8 | 9.1 | 90.9 |
| 4 | 9.2 | 0.7 | 9.9 | 90.1 | |
| 6 | 10.3 | 1.2 | 11.5 | 88.5 | |
| 12 | 2.5 | 1.6 | 4.1 | 95.9 | |
| 24 | 3.9 | 1.2 | 5.1 | 94.9 | |
| 72 | 2.4 | 2.4 | 4.8 | 95.2 |
*
Sum of dextran within the facial and cervical lymph nodes.